CAS Number: 154598-52-4
Anti-HIV drug. There is not experience on children younger than 3 years old. Mothers must be adviced that transmission of HIV infection through breastfeeding has been documented.
CAS Number: 154635-17-3
In the United States and other developed countries, HIV-infected mothers should generally not breastfeed their infants. Published experience with efavirenz during breastfeeding is limited. In countries in which no acceptable, feasible, sustainable and safe replacement feeding is available, World Health Organization guidelines recommend that all women with an HIV infection who are pregnant or breastfeeding should be maintained on antiretroviral therapy for at least the duration of risk for mother-to-child transmission. Mothers should exclusively breastfeed their infants for the first 6 months of life; breastfeeding with complementary feeding should continue through at least 12 months of life up to 24 months of life. The first choice regimen for nursing mothers is tenofovir, efavirenz and either lamivudine or emtricitabine. If these drugs are unavailable, alternative regimens include: 1) zidovudine, lamivudine and efavirenz; 2) zidovudine, lamivudine and nevirapine; or 3) tenofovir, nevirapine and either lamivudine or emtricitabine. Exclusively breastfed infants should also receive 6 weeks of prophylaxis with nevirapine. Treatment of mothers of HIV+ mothers with efavirenz as part of Option B+ therapy does not appear to affect growth of their HIV-negative breastfed infants.
We have already established that Atripla | Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate Tablet is unsafe in breastfeeding and breastfeeding while using Atripla | Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate Tablet is not a good idea however if have already used
If your doctor knows that you are breastfeeding mother and still prescribes Atripla | Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate Tablet then there must be good reason for that as Atripla | Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate Tablet is considered unsafe, It usually happens when doctor finds that overall advantage of taking
Yes, Extra monitoring is required if mother is using Atripla | Efavirenz, Emtricitabine, And Tenofovir Disoproxil Fumarate Tablet and breastfeeding as it is considered unsafe for baby.
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week